Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;8(3):9-13.

Phosphatonins: new hormones involved in numerous inherited bone disorders

Laura Masi  1
Affiliations

Phosphatonins: new hormones involved in numerous inherited bone disorders

Laura Masi. Clin Cases Miner Bone Metab. 2011 Sep.

Abstract

Phosphate (Pi) homeostasis is under control of several endocrine factors that play effects on bone, kidney and intestine. The control of Pi homeostasis has a significant biological importance, as it relates to numerous cellular mechanisms involved in energy metabolism, cell signaling, nucleic acid synthesis, membrane function, as well as skeletal health and integrity. Pi is essential for diverse biological processes, and negative Pi balance resulting from improperly regulated intestinal absorption, systemic utilization, and renal excretion. As results of these functions, chronic Pi deprivation causes several biological alterations, such as bone demineralization with unmineralized osateoid typical of osteomalacia in adults and rickets in developing animals and humans (1). Phosphatonins are new hormones playing an important role in the control of Pi homeostasis together with parathyroid hormone (PTH) and 1,25-dihydroxy vitamin D(3). Most insight into the underlying mechanisms was established by defining the molecular basis of different inherited disorders that are characterized by an abnormal regulation of Pi homeostasis.

Keywords: bone metabolism; genetic disorders; phosphate homeostasis; phosphatonins.

PubMed Disclaimer

References

    1. Marcucci G, Masi L, Brandi ML. Phosphatonins: new hormones that control phosphorus homeostasis. Expert Rev Endocrinol Metab. 2008;3:3–14. - PubMed
    1. Kiela PR, Ghishan FK. Recent advances in the renal–skeletal–gut axis that controls phosphate homeostasis. Laboratory Investigation. 2009;89:7–14. - PMC - PubMed
    1. Miyamoto K, Ito M, Tatsumi S, Kuwahata M, Segawa H. New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter. Am J Nephrol. 2007;27:503–15. - PubMed
    1. Sommer S, Berndt T, Craig T, Kumar R. The phosphatonins and the regulation of phosphate transport and vitamin D metabolism. J Steroid Biochem Mol Biol. 2007;103:497–503. - PubMed
    1. Barthel TK, Mathern DR, Whitfield GK, Haussler CA, Hopper HA, 4th, Hsieh JC, Slater SA, Hsieh G, Kaczmarska M, Jurutka PW, Kolek OI, Ghishan FK, Haussler MR. 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism. J Steroid Biochem Mol Biol. 2007;103:381–8. - PubMed

LinkOut - more resources